Old Web
English
Sign In
Acemap
>
Paper
>
OP414 The Influence Of Cost-Effectiveness Evidence And Other Factors On China's National Reimbursement Drug Listing Decisions
OP414 The Influence Of Cost-Effectiveness Evidence And Other Factors On China's National Reimbursement Drug Listing Decisions
2020
Thomas Butt
Daniel A. Ollendorf
Renxing Zhao
Gordon G. Liu
Keywords:
China
cost effectiveness
Actuarial science
Drug
Reimbursement
Business
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]